Pliant Therapeutics Inc

Research Pliant Therapeutics Inc (PLRX) on Bullrun: market cap USD 71.21M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerPLRX
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 71.21M
• Financial periodFY2025
• Net incomeUSD 149.30M
• Free cash flow-USD 128.71M

Valuation Snapshot

latest market cap is USD 71.21M.

About Pliant Therapeutics Inc

Pliant Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing integrin-based therapeutics for the treatment of solid tumors. The company's lead product candidate is the PLN-101095, an oral, small molecule dual inhibitor of avß8 and avß1 integrins that is in Phase 1a/1b for the treatment of solid tumors.

Frequently asked questions

What is Pliant Therapeutics Inc's market cap?

Pliant Therapeutics Inc's market capitalization is USD 71.21M.

What does Pliant Therapeutics Inc do?

Pliant Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing integrin-based therapeutics for the treatment of solid tumors.